Latest AI and machine learning research in dyslipidemia for healthcare professionals.
BACKGROUND: Gestational diabetes mellitus (GDM) affects 15-25% of pregnancies worldwide and poses serious risks of macrosomia, preeclampsia, neonatal hypoglycaemia, and long-term type 2 diabetes. Existing machine learning models lack prospective multi-site external validation and formal physician trust evaluation, limiting real-world applicability. OBJECTIVES: To develop a clinically validated, ex...
INTRODUCTION AND HYPOTHESIS: Preoperative lower-extremity venous thrombosis (LEVT) is frequently overlooked in women undergoing pelvic organ prolapse (POP) surgery, despite its potential impact on perioperative outcomes. Conventional risk tools, including the Caprini score and D-dimer, show limited performance in this population, and the true prevalence of occult preoperative LEVT remains uncertai...
Hepatocellular carcinoma (HCC) remains a therapeutic challenge due to tumor microenvironment heterogeneity and metabolic reprogramming. DHRS3, a retin...
BACKGROUND: Coal-dust, a persistent airborne pollutant, induces dose-related pulmonary fibrosis; however, plasma biomarkers for pre-clinical toxicity ...
BACKGROUND: Sleep apnea syndrome (SAS) is closely related to an increased risk of non-alcoholic fatty liver disease (NAFLD), but current clinical tool...
BACKGROUND: Acute myocardial infarction (AMI) remains a leading cause of global morbidity and mortality, with early prediction critical for timely int...
OBJECTIVE: Dysregulation of Cholesterol homeostasis(CH) and NK cells proportion can increase risk of ST-Elevated Myocardial Infarction(STEMI) for Coro...
BACKGROUND: Circadian syndrome (CircS) augments the conventional metabolic syndrome construct by adding disturbed sleep and depressive features. Wheth...
BACKGROUND: Based on machine learning prediction models, we explored the anemia treatment attainment of patients on maintenance hemodialysis (MHD) and...
BACKGROUND AND AIMS: Atherosclerosis results from cellular and extracellular changes in the arterial wall, preceded by molecular shifts that initiate ...
Peripheral artery disease (PAD) is a common manifestation of atherosclerotic cardiovascular disease (ASCVD) that is underdiagnosed in clinical practic...
BACKGROUND: Diabetic retinopathy (DR) is a leading cause of vision loss, yet conventional retinal screening remains costly and resource-intensive. Thi...
BACKGROUND: Lean metabolic dysfunction-associated fatty liver disease (MAFLD) is increasingly recognized but often goes unnoticed during health checku...
BACKGROUND: The rising incidence of youth-onset type 2 diabetes mellitus (T2DM), along with the risk of early cardiovascular complications, is concern...
Hypercholesterolemia is a pivotal risk factor for cardiovascular diseases, and its effective management is critical to reducing cardiovascular event i...
BACKGROUND: While the single-point insulin sensitivity estimator (SPISE) shows promise as an insulin resistance biomarker, its association with cardio...
BACKGROUND: Chronic Obstructive Pulmonary Disease (COPD) and Heart Failure with preserved Ejection Fraction (HFpEF) frequently coexist, leading to inc...
BACKGROUND: Atherosclerosis (AS) is a chronic inflammatory vascular disease that can lead to severe cardiovascular events. Ferroptosis and autophagy h...
INTRODUCTION: The prevalence of Parkinson's disease (PD) has increased globally, especially in China, and emerged as a critical public health challeng...
BACKGROUND: Atherosclerosis (AS) is a major global health burden. Sodium nitrite, a common environmental and dietary contaminant, has been implicated ...